Cardinal Health, Inc. $CAH Shares Acquired by Sigma Planning Corp

Sigma Planning Corp boosted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 31.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,126 shares of the company’s stock after acquiring an additional 3,379 shares during the period. Sigma Planning Corp’s holdings in Cardinal Health were worth $3,356,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. University of Texas Texas AM Investment Management Co. purchased a new position in Cardinal Health in the 4th quarter worth approximately $26,000. Bank of Jackson Hole Trust acquired a new stake in shares of Cardinal Health in the fourth quarter valued at approximately $27,000. Jones Financial Companies Lllp increased its holdings in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the last quarter. Palladiem LLC purchased a new position in Cardinal Health during the fourth quarter worth approximately $28,000. Finally, Indiana Trust & Investment Management Co purchased a new position in Cardinal Health during the first quarter worth approximately $29,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Insider Buying and Selling at Cardinal Health

In related news, CEO Deborah Weitzman sold 7,354 shares of the stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total transaction of $1,731,499.30. Following the completion of the transaction, the chief executive officer owned 77,901 shares of the company’s stock, valued at approximately $18,341,790.45. This trade represents a 8.63% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Mary C. Scherer sold 2,302 shares of Cardinal Health stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $237.39, for a total transaction of $546,471.78. Following the completion of the sale, the chief accounting officer owned 2,811 shares of the company’s stock, valued at $667,303.29. This trade represents a 45.02% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 210,271 shares of company stock valued at $49,626,657. 0.12% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Wells Fargo & Company upped their target price on Cardinal Health from $245.00 to $277.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Weiss Ratings lowered shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Wednesday, August 19th. Citigroup raised their price objective on shares of Cardinal Health from $265.00 to $280.00 and gave the stock a “buy” rating in a research report on Wednesday, August 12th. UBS Group lifted their target price on shares of Cardinal Health from $274.00 to $280.00 and gave the stock a “buy” rating in a research note on Wednesday, August 12th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Cardinal Health from $215.00 to $260.00 and gave the company a “neutral” rating in a report on Thursday, August 13th. Sixteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $266.56.

Cardinal Health Stock Up 0.1%

CAH stock opened at $234.72 on Monday. Cardinal Health, Inc. has a 52-week low of $145.87 and a 52-week high of $258.30. The stock has a market cap of $54.59 billion, a price-to-earnings ratio of 32.46, a price-to-earnings-growth ratio of 1.41 and a beta of 0.49. The business has a fifty day moving average of $233.10 and a two-hundred day moving average of $218.37.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, beating the consensus estimate of $2.42 by $0.49. The business had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The company’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 12.55 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is 28.49%.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.